MeiraGTx Holdings PLC (MGTX)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$9.04
Buy
$9.70
$0.09 (+0.99%)
Prices updated at 02 Apr 2026, 22:23 EDT
| Prices minimum 15 mins delay
Prices in USD
MeiraGTx Holdings PLC is a clinical stage gene therapy company. Its pipeline products include AAV-CNGB3, AAV-CNGA3. AAV-UPF1, West AMD, Dry AMD, and others. Geographically, the company generates a majority of its revenue from the United Kingdom.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Biotechnology
Chairman
Dr. Keith R. Harris, PhD
CEO
Dr. Alexandria Forbes, PhD
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
403
Head office
655 Third Avenue
New York
United States
10017
Key personnel
Owner name | Salary |
|---|---|
Dr. Thomas E. Shenk, PhD Independent Director | 0.09m |
Ms. Nicole Seligman Independent Director | 0.10m |
Dr. Alexandria Forbes, PhD President, Chief Executive Officer and Director | 0.84m |
Mr. Richard Giroux Chief Accounting Officer, Chief Operating Officer and Chief Financial Officer | 0.71m |
Dr. Keith R. Harris, PhD Chairman of the Board | 0.16m |
Dr. Ellen Hukkelhoven, PhD Director | - |
Lord Neil Mendoza Independent Director | 0.10m |
Dr. Debra Yu, M.D. Independent Director | 0.08m |
Dr. Stuart Naylor, PhD Chief Development Officer | 0.50m |
Dr. Robert K. Zeldin, M.D. Chief Medical Officer | - |
Mr. Robert J. Wollin General Counsel and Secretary | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| Perceptive Advisors LLC | 12,626,103 |
| Sanofi | 12,197,737 |
| Johnson & Johnson | 6,641,064 |
| Rubric Capital Management LP | 6,175,331 |
| Adage Capital Partners Gp LLC | 4,000,000 |
Director dealings
Date | Action |
|---|---|
| 23 Dec 2025 | - |
| 20 Nov 2025 | - |
| 21 Oct 2025 | - |
| 07 Oct 2025 | - |
| 22 Jul 2025 | - |
| 08 Jul 2025 | - |
| 30 Jun 2025 | - |
| 12 Jun 2025 | - |
| 12 Jun 2025 | - |
| 12 Jun 2025 | - |
| 12 Jun 2025 | - |
| 12 Jun 2025 | - |
| 12 Jun 2025 | - |
| 06 Jun 2025 | - |
| 06 Jun 2025 | - |
| 22 Apr 2025 | - |
| 08 Apr 2025 | - |
| 03 Apr 2025 | - |
| 03 Apr 2025 | - |
| 03 Apr 2025 | - |
Please note that past performance is not a reliable indicator of future returns.